Pathophysiology And Alternative Preventative Strategy For Breast Cancer Chemotherapy-induced Bone Loss
Funder
National Health and Medical Research Council
Funding Amount
$540,356.00
Summary
Combination cytotoxic chemotherapy is the current optimal approach for treating breast cancer in premenopausal women. However, long-term skeletal defects (osteoporosis and fractures) caused by the chemotherapy have become an increasingly serious problem due to its intensified use and improved patient survival rate. This project seeks to elucidate the mechanisms for chemotherapy-induced bone defects and to initiate development of a preventative treatment using natural bioactive micronutrients.
Role Of The MiR-200 Target Quaking In Alternative Splicing During EMT And Cancer Progression
Funder
National Health and Medical Research Council
Funding Amount
$443,160.00
Summary
The spread of cancer to other organs involves cancer cells changing to a more aggressive state and is a major cause of cancer related death. MicroRNAs are a class of genes that control whether cancer cells become more aggressive by regulating other genes. In this project we will examine the function of a new microRNA target which controls the cancer cell aggression. The outcome will be a better understanding of how cancers spread and the identification of new therapeutic targets.
Characterising Novel Alternative Splicing Networks That Promote Tumour Cell Plasticity
Funder
National Health and Medical Research Council
Funding Amount
$609,329.00
Summary
During cancer progression, tumour cells can change their properties and become more aggressive and resistant to therapies. We have identified an important regulator of this tumour cell transition, called “Quaking”, which causes widespread changes in gene splicing. We aim to investigate how "Quaking" causes changes in gene splicing and what the effects of these splicing changes are in tumour cells.
New understanding of turbulent flames with soot and particulate fuels. This project will develop the new understanding and models required to optimise practical furnaces, boilers and combustion chambers, most of which involve soot and/or particulate fuels. This work will be performed with state-of-the-art measurement and modelling tools through a well-established partnership of international researchers.
Pharmacological investigation of medicinal plant products from Kaanju Homelands, Wenlock and Pascoe Rivers, Cape York Peninsula. This research will examine the potential for products to be developed from plants on Kaanju homelands. Kaanju people have an immense ecological knowledge accumulated over generations, about the natural resources in an area recognised as being one of Australia's most biologically diverse. Preservation of this knowledge is critical not only to Kaanju people but to the he ....Pharmacological investigation of medicinal plant products from Kaanju Homelands, Wenlock and Pascoe Rivers, Cape York Peninsula. This research will examine the potential for products to be developed from plants on Kaanju homelands. Kaanju people have an immense ecological knowledge accumulated over generations, about the natural resources in an area recognised as being one of Australia's most biologically diverse. Preservation of this knowledge is critical not only to Kaanju people but to the heritage of the Nation as a whole. The research also addresses the National priority 'Promoting & maintaining good health' through the investigation of novel pharmacological activities in areas of cardiovascular health, diabetes and cancer. The collaborative research partnership will serve as a model to assist other Aboriginal organisations, particularly in rural & remote areas.Read moreRead less
Integrated photo and thermal catalysis for economic carbon dioxide conversion to fuels. The project aims to develop an integrated process for simultaneously photo- and thermal-catalytic conversion of carbon dioxide and water vapour to hydrocarbon fuels and chemicals using solar light and waste heat from flue gas. This project will design and make multi-functional catalysts based on zirconium metal organic frameworks, incorporating quantum dots and metal nanoclusters. This project is expected to ....Integrated photo and thermal catalysis for economic carbon dioxide conversion to fuels. The project aims to develop an integrated process for simultaneously photo- and thermal-catalytic conversion of carbon dioxide and water vapour to hydrocarbon fuels and chemicals using solar light and waste heat from flue gas. This project will design and make multi-functional catalysts based on zirconium metal organic frameworks, incorporating quantum dots and metal nanoclusters. This project is expected to develop an advanced materials system, reduce carbon dioxide and use it to produce fuel, and harness solar energy. The project should advance Australia’s leading role in reducing carbon emission, and producing clean energy and nanotechnology.Read moreRead less
Enhanced mixing of turbulent jet flames via side lateral injection. This innovative project will contribute significantly to the reduction of pollutant emissions from combustion of fossil and bio-fuels through new and innovative mixing approach of fuel and oxidant. It will facilitate a range of new devices with broader application leading to export earnings, local employment and reduction of our carbon footprint.
Can Decision Analytic Modelling Promote Clinical Translation Of Personalised Medicine Markers For Oncology Drugs?
Funder
National Health and Medical Research Council
Funding Amount
$69,893.00
Summary
Personalised medicine is an approach that has great potential to improve healthcare. There has been limited success to date, however, in utilising proposed tests in the clinical. It is proposed that use of mathematical models early in the development of personalised medicine tests will allow early understanding of the value that the test will have for patients and society. Such insight will help build a strong case to undertake the research required before personalised medicine can be more widel ....Personalised medicine is an approach that has great potential to improve healthcare. There has been limited success to date, however, in utilising proposed tests in the clinical. It is proposed that use of mathematical models early in the development of personalised medicine tests will allow early understanding of the value that the test will have for patients and society. Such insight will help build a strong case to undertake the research required before personalised medicine can be more widely used to improve treatment for cancer.Read moreRead less
Molecular hallmarks of androgen receptor targeting in prostate cancer. There is a critical need in oncology drug development for better biomarkers of response to prostate cancer therapies, clinically to assist with treatment decision making, and pre-clinically to facilitate translation of emerging agents into clinical practice. Using a unique explant culture model, this project will identify protein and lipid markers that can be used to accurately and reliably assess response to androgen recepto ....Molecular hallmarks of androgen receptor targeting in prostate cancer. There is a critical need in oncology drug development for better biomarkers of response to prostate cancer therapies, clinically to assist with treatment decision making, and pre-clinically to facilitate translation of emerging agents into clinical practice. Using a unique explant culture model, this project will identify protein and lipid markers that can be used to accurately and reliably assess response to androgen receptor (AR)-targeting therapies in human prostate tumours. The identification and functional assessment of these biomarkers will identify those that can be used as surrogate endpoints in clinical trials, facilitate earlier approval of investigational agents and lead to improved options for therapeutic management of prostate cancer.Read moreRead less
Personalised Medicine Markers Of Anti-EGFR Antibody Therapy In Metastatic Colorectal Cancer: Accelerating Clinical Translation With Collaborative Meta-analyses Based On Individual-participant Data
Funder
National Health and Medical Research Council
Funding Amount
$300,953.00
Summary
When selecting cancer therapy we take into account ‘biomarkers’, biological cancer characteristics that predict treatment success. We will work with an international group, the Advanced Colorectal Cancer Database, to analyse individual patient clinical trial data. We intend to validate biomarkers used to select treatment with cetuximab or panitumumab. Cancer genes called KRAS, NRAS, PTEN, PIK3CA, EREG and BRAF will be examined. Our study will provide best evidence for personalised treatment.